Join
Live feed
·
SECFilingvia Quantisnow
Akari Therapeutics plc logo

Akari Therapeutics plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Termination of a Material Definitive Agreement, Regulation FD Disclosure

ByQuantisnow·Wall Street's wire, on your screen.
AKTX· Akari Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTX (Akari Therapeutics plc) and more on Quantisnow.